# Open-label Investigation of the Safety and Effectiveness of DIABECELL(R) in Patients With Type I Diabetes Mellitus

> **NCT00940173** · PHASE1,PHASE2 · COMPLETED · sponsor: **Diatranz Otsuka Limited** · enrollment: 16 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DEVICE:** DIABECELL(R)
- **DEVICE:** DIABECELL(R)
- **DEVICE:** DIABECELL(R)
- **DEVICE:** DIABECELL(R)

## Key facts

- **NCT ID:** NCT00940173
- **Lead sponsor:** Diatranz Otsuka Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00940173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00940173, "Open-label Investigation of the Safety and Effectiveness of DIABECELL(R) in Patients With Type I Diabetes Mellitus". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT00940173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*